Filtration surgery rates drop

Article

The introduction of anti-glaucoma medications has reduced the need for filtration surgery, according to study results published online ahead of print by Eye.

The introduction of anti-glaucoma medications has reduced the need for filtration surgery, according to study results published online ahead of print by Eye.

P.A. Keane of the Department of Ophthalmology at Waterford Regional Hospital, Ireland and colleagues conducted a 20-year retrospective review of patients undergoing glaucoma filtration surgery (n=760) at Waterford Regional Hospital between January 1986 and December 2005.

Over the review period, three new anti-glaucoma medicines became available. The number of filtration surgeries performed fell annually: from 1986–1995, the mean annual figure was 23.75 per surgeon; by the 1998–2005 period, this had fallen to 12.69 procedures per surgeon per year. The age of patients undergoing surgery did not decrease across the review period.

The team concluded that, as the decrease in filtration surgeries was not correlated to patient age, the introduction of topical anti-glaucoma medication was the most likely cause for the reduction, although it remains unclear whether this is an absolute reduction or merely a delay in the need for surgery.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.